Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study

NCT01158755 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Meningitis, Tuberculous
Pharmacokinetics
Pharmacodynamics
Tolerability

Interventions

DRUG: Moxifloxacin

Sponsor

Universitas Padjadjaran

Collaborators

[object Object]